bluebird bio+-+-Motley Fool+-+-cystic fibrosis+-+-Merck+-+-Biogen+-+-Vertex Pharmaceuticals+-+-extremely limited indication+-+-lentiviral-vector derived product+-+-BACE inhibitor E2609+-+-cystic fibrosis patients+-+-Keytruda blocks tumor+-+-private U.K. company+-+-annual sales+-+-IDO1 inhibitor+-+-cystic fibrosis space+-+-forward earnings+-+-IDO1 inhibitors+-+-annual product sales+-+-short amino acid+-+-Foolish newsletter services+-+-52-times forward earnings+-+-disclosure policy+-+-times forward earnings+-+-moon-shootersMerck+-+-lentiviral-vector based programs+-+-similar early-stage competitors+-+-traditional valuation metrics+-+-melanoma patients+-+-Vertex shares+-+-uppercase consonants+-+-Image source+-+-cellular-therapy biotechs+-+-small groups+-+-Keytruda sales+-+-life-threatening diseases+-+-amazing results+-+-risk tolerance+-+-subsequent approvals+-+-First-quarter earnings+-+-big gains+-+-new therapies+-+-larger indications+-+-good news+-+-golden rules+-+-Alzheimer+-+-long-term losses+-+-tumor types.+-+-steady profits+-+-clinicaltrials+-+-PD-1 blockers+-+-disease moonshot+-+-small bunches+-+-safest alternative+-+-tumor types+-+-PD-1 pathway+-+-Warren Buffett+-+-Collaborations galore+-+-Joshua Boger+-+-pharmaceutical company+-+-disease progression+-+-latest expansion+-+-label expansions+-+-big cake+-+-big drugmakers+-+-big implications+-+-aducanumab trials+-+-North America+-+-complex diseases+-+-best shot+-+-CFTR gene+-+-combination studies+-+-dense plaques+-+-immense sums+-+-sustainable profitability+-+-healthcare providers+-+-new kind+-+-Cory Renauer+-+-diverse range+-+-positive revenue+-+-uncharted waters+-+-safer bet+-+-pharmacy shelves+-+-better investors+-+-average stock+-+-Better Buys+-+-NASDAQ+-+-study+-+-treatments+-+-level+-+-data+-+-moment+-+-moonshots+-+-market+-+-Orkambi+-+-FDA+-+-phase+-+-combinations+-+-stocks+-+-VRTX+-+-disdain+-+-Incyte+-+-operations+-+-financing+-+-Fool.com+-+-dementias+-+-ambitions+-+-mentality+-+-icing+-+-companies+-+-MRK+-+-BIIB+-+-investment+-+-epacadostat+-+-candidates.+-+-rights+-+-bank+-+-amyloid-+-+-boardroom+-+-Eisai+-+-solution+-+-U.S.+-+-win+-+-period+-+-treatment+-+-cases+-+-Europe+-+-Australia+-+-handful+-+-standpoint+-+-sort+-+-Kalydeco+-+-opinions+-+-LLC+-+-room+-+-S&P+-+-odds+-+-article+-+-Inc.+-+-dominance+-+-Fools+-+-NYSE+-+-mosaic+-+-targets+-+-pair+-+-mutations+-+-hypothesis+-+-cash